Internal Medicine, Endocrinology, Diabetes, & Metabolism · White Hall, AR
NPI
1801901509
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7500 Dollarway Rd, Suite 404
White Hall, AR, 71602
Phone (870) 879-9595
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,192 services
Medicare patients, 2024
598
Average age 72
Drug cost, 2024
$6.4M
9,662 prescriptions
Company payments, 2025
$2,686
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maher Alesali was code 99213 (office e&m - established), 751 times for 467 patients. In total Maher Alesali billed 1,192 services in 4 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 751 | 467 | $46.27 | $35K |
| 99214 Office E&M - Established | Office | 307 | 305 | $54.49 | $17K |
| 99205 Office E&M - New | Office | 128 | 128 | $117.20 | $15K |
By year: 2022 $81K for 1,458 services; 2023 $73K for 1,232 services; 2024 $67K for 1,192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maher Alesali prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 960 prescriptions and refills. In total Maher Alesali wrote 9,662 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 960 | 1,185 | 181 | $695K |
| Ozempic Semaglutide | 936 | 1,136 | 179 | $1.1M |
| Mounjaro Tirzepatide | 904 | 984 | 134 | $1.1M |
| Levothyroxine Sodium Generic | 822 | 1,221 | 158 | $4,388 |
| Farxiga Dapagliflozin Propanediol | 612 | 770 | 108 | $429K |
| Tresiba Flextouch U-100 Insulin Degludec | 543 | 802 | 124 | $387K |
| Metformin Hcl Generic | 477 | 790 | 108 | $2,340 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 262 | 376 | 58 | $186K |
| Tresiba Flextouch U-200 Insulin Degludec | 233 | 316 | 46 | $335K |
| Trulicity Dulaglutide | 222 | 245 | 38 | $228K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 191 | 269 | 50 | $39K |
| Humalog Kwikpen U-100 Insulin Lispro | 186 | 326 | 60 | $66K |
| Synthroid Levothyroxine Sodium | 177 | 249 | 37 | $11K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 170 | 238 | 47 | $13K |
| Methimazole Generic | 164 | 212 | 42 | $1,286 |
Brand drugs: 7,095 claims; generic drugs: 1,887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maher Alesali $2,686 ($2,686 in general payments such as food, travel and fees) from 19 companies. The largest payer was Corcept Therapeutics with $668.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 30 | $668 |
| Novo Nordisk Inc NVO | 18 | $327 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $313 |
| Dexcom, Inc. DXCM | 19 | $269 |
| Xeris Pharmaceuticals, Inc. | 13 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $175 |
| Sequel Med Tech, LLC | 3 | $152 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $141 |
| CeQur Corporation | 2 | $97.1 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $77.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.